| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 89671 | Ascotoxin | 0.0238174255956147 | -0.03984642 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.024108502230778 | 0.48089708 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.024108502230778 | 0.45541617 |
| NSC 164970 | Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- | 0.024108502230778 | 0.33987962 |
| NSC 292816 | 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) | 0.024108502230778 | -0.0090050579 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.024108502230778 | 0.30981538 |
| NSC 58574 | Pyrimidine, 2,4,5-trichloro-6-propyl- | 0.024108502230778 | 0.42990488 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 0.024108502230778 | 0.55769519 |
| NSC 628949 | Null | 0.024108502230778 | 0.37516929 |
| NSC 630252 | Null | 0.024108502230778 | 0.71860318 |